garenoxacin has been researched along with venlafaxine hydrochloride in 1 studies
Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (venlafaxine hydrochloride) | Trials (venlafaxine hydrochloride) | Recent Studies (post-2010) (venlafaxine hydrochloride) |
---|---|---|---|---|---|
195 | 19 | 46 | 2,846 | 686 | 1,136 |
Protein | Taxonomy | garenoxacin (IC50) | venlafaxine hydrochloride (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.9466 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.18 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.55 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahmood, I | 1 |
1 other study(ies) available for garenoxacin and venlafaxine hydrochloride
Article | Year |
---|---|
Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach.
Topics: Administration, Oral; Animals; Body Weight; Enoxacin; Fluoroquinolones; Half-Life; Humans; Linezolid; Metabolic Clearance Rate; Models, Biological; Monosaccharides; Sildenafil Citrate; Triazoles; Venlafaxine Hydrochloride | 2016 |